Regulatory Update: Randomized Trial Evaluates Virtual Reality Supported Task Oriented Training for Rotator Cuff Lesions

By Dr. Hatem Rabeh · Published February 12, 2026 · Updated March 16, 2026

What is this trial about?

The registry describes a randomized controlled trial that compares conventional treatment with a virtual reality supported task oriented training for rotator cuff lesions. The aim is to observe potential improvements in rehabilitation performance and to note any safety signals related to the training approach. The trial status is not yet recruiting and the sponsor is Kirsehir Ahi Evran Universitesi. No outcomes are reported in the registry at this time. The entry demonstrates an interest in adding digital training components to standard shoulder care while complying with registry requirements for trial documentation.

How is the trial designed?

The entry outlines a randomized controlled design with parallel groups. It lists two intervention arms in the registry: conventional treatment and Virtual Reality Supported Task Oriented Training. No results are available yet in the registry and the recruitment status remains not yet recruiting. The description implies a direct comparison aimed at informing safety and performance in real world rehabilitation settings while conforming to good clinical practice for trial conduct.

What interventions are studied?

The trial lists two arms. One uses conventional treatment for shoulder injuries. The other uses Virtual Reality Supported Task Oriented Training. The registry does not specify whether VR training is used in addition to conventional care or as a stand alone option, so readers should review the registry details for clarification. The sponsor is Kirsehir Ahi Evran Universitesi and the description emphasizes a training based approach rather than a purely pharmacologic or surgical intervention in this context.

What is the regulatory context for this trial?

As an entry on ClinicalTrials.gov the project reflects documented intended use and safety considerations for a device assisted rehabilitation approach. In line with medical device regulatory thinking the registry supports discussion of intended purpose, performance expectations and safety controls. Manufacturers would typically need to provide risk management data and monitoring for any training device component used in the trial to support future regulatory submissions and post market oversight.

Who should care and why?

Clinicians and researchers may monitor the development of virtual reality based rehabilitation tools for rotator cuff lesions. If outcomes indicate benefit this could influence future device submissions and adoption in clinical practice. Regulators and payers may track the trial status to gauge when evidence may become actionable. All statements refer to the registry information and have not been validated by trial results at this time.